0
Signin
countryflagUS

18889881171

MSFT 425.025 -0.9035% AAPL 220.43 0.8648% NVDA 115.85 1.4004% GOOGL 172.44 -0.1101% GOOG 174.27 -0.0573% AMZN 182.99 1.1945% META 460.09 -0.2558% AVGO 152.64 0.859% TSLA 224.8499 4.102% TSM 161.61 1.1327% LLY 823.56 -4.2238% V 257.56 1.3338% JPM 209.535 0.453% UNH 562.83 0.5502% NVO 129.31 -1.7401% WMT 70.206 -0.5581% LVMUY 143.15 0.9022% XOM 116.85 1.5999% LVMHF 714.04 0.4982% MA 436.96 1.0429%

THC Farmaceuticals Inc

Healthcare US CBDG

0.025USD
0.0085(51.52%)

Last update at 2024-07-24T13:30:00Z

Day Range

0.030.03
LowHigh

52 Week Range

0.00040.21
LowHigh

Fundamentals

  • Previous Close 0.02
  • Market Cap7.35M
  • Volume582
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-0.06943M
  • Revenue TTM0.02M
  • Revenue Per Share TTM0.001
  • Gross Profit TTM 0.00673M
  • Diluted EPS TTM-

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2014-09-30 2013-09-30 2012-09-30 2011-09-30
Type yearly yearly yearly yearly
Date 2014-09-30 2013-09-30 2012-09-30 2011-09-30
Income before tax -0.03070M -0.02384M -0.03969M -0.02836M
Minority interest 0.00000M 0.00000M 0.00000M 0.00000M
Net income -0.03070M -0.02384M -0.03969M -0.02836M
Selling general administrative 0.03M 0.02M 0.04M 0.04M
Selling and marketing expenses - - - -
Gross profit 0.00673M 0.00484M 0.01M 0.02M
Reconciled depreciation - - - -
Ebit -0.02402M -0.01959M -0.02353M -0.02375M
Ebitda - - - -
Depreciation and amortization - - - -
Non operating income net other - - - -
Operating income -0.02402M -0.01959M -0.02353M -0.02375M
Other operating expenses 0.00076M 0.00142M 0.00184M 0.00000M
Interest expense 0.00000M 0.00000M 0.00000M 0.00000M
Tax provision - - - -
Interest income - - - -
Net interest income - - - -
Extraordinary items 0.00000M 0.00000M 0.00000M 0.00000M
Non recurring 0.00000M 0.00000M 0.01M 0.00000M
Other items 0.00000M 0.00000M 0.00000M 0.00000M
Income tax expense 0.00000M 0.00000M 0.00000M 0.00000M
Total revenue 0.02M 0.02M 0.03M 0.03M
Total operating expenses 0.04M 0.04M 0.05M 0.06M
Cost of revenue 0.01M 0.02M 0.02M 0.01M
Total other income expense net -0.00668M -0.00425M -0.01616M -0.00461M
Discontinued operations 0.00000M 0.00000M 0.00000M 0.00000M
Net income from continuing ops -0.03070M -0.02384M -0.03969M -0.02836M
Net income applicable to common shares -0.03070M -0.02384M -0.03969M -0.02836M
Preferred stock and other adjustments - - - -
Breakdown 2014-09-30 2013-09-30 2012-09-30 2011-09-30
Type yearly yearly yearly yearly
Date 2014-09-30 2013-09-30 2012-09-30 2011-09-30
Total assets 0.05M 0.05M 0.05M 0.07M
Intangible assets 0.03M 0.03M 0.03M 0.04M
Earning assets - - - -
Other current assets 0.00000M 0.00000M 0.00000M 0.00000M
Total liab 0.10M 0.07M 0.05M 0.02M
Total stockholder equity -0.04802M -0.01732M 0.00652M 0.05M
Deferred long term liab 0.00000M 0.00000M 0.00000M 0.00000M
Other current liab 0.00000M 0.00000M 0.00000M 0.00000M
Common stock 0.00897M 0.00897M 0.00897M 0.00897M
Capital stock - - - -
Retained earnings -0.14086M -0.11016M -0.08632M -0.04663M
Other liab 0.01M 0.00585M 0.00160M 0.00000M
Good will 0.00000M 0.00000M 0.00000M 0.00000M
Other assets 0.00000M 0.00000M 0.00000M 0.00775M
Cash 0.00064M 0.00058M 0.00231M 0.00412M
Cash and equivalents - - - -
Total current liabilities 0.00598M 0.00324M 0.00762M 0.00260M
Current deferred revenue - - - -
Net debt - - - -
Short term debt 0.10M 0.00184M 0.00526M 0.02M
Short long term debt 0.10M 0.00184M 0.00526M 0.02M
Short long term debt total - - - -
Other stockholder equity 0.00000M 0.00000M 0.00000M 0.00000M
Property plant equipment 0.01M 0.01M 0.01M 0.00831M
Total current assets 0.00239M 0.00232M 0.00434M 0.00627M
Long term investments 0.00000M 0.00000M 0.00000M 0.00000M
Net tangible assets -0.08169M -0.05099M -0.02716M 0.00273M
Short term investments 0.00000M 0.00000M 0.00000M 0.00000M
Net receivables 0.00175M 0.00174M 0.00203M 0.00215M
Long term debt 0.08M 0.06M 0.04M 0.02M
Inventory 0.00000M 0.00000M 0.00000M 0.00000M
Accounts payable 0.00508M 0.00189M 0.00096M 0.00087M
Total permanent equity 0.00000M 0.00000M 0.00000M 0.00000M
Noncontrolling interest in consolidated entity 0.00000M 0.00000M 0.00000M 0.00000M
Temporary equity redeemable noncontrolling interests 0.00000M 0.00000M 0.00000M 0.00000M
Accumulated other comprehensive income 0.00000M 0.00000M 0.00000M 0.00000M
Additional paid in capital 0.00000M 0.00000M 0.00000M 0.00000M
Common stock total equity 0.00000M 0.00000M 0.00000M 0.00000M
Preferred stock total equity 0.00000M 0.00000M 0.00000M 0.00000M
Retained earnings total equity 0.00000M 0.00000M 0.00000M 0.00000M
Treasury stock 0.00000M 0.00000M 0.00000M 0.00000M
Accumulated amortization - - - -
Non currrent assets other - - - -
Deferred long term asset charges - - - -
Non current assets total - - - -
Capital lease obligations - - - -
Long term debt total - - - -
Breakdown 2014-09-30 2013-09-30 2012-09-30 2011-09-30
Type yearly yearly yearly yearly
Date 2014-09-30 2013-09-30 2012-09-30 2011-09-30
Investments 0.00000M 0.00000M 0.00000M 0.00000M
Change to liabilities 0.00458M -0.00096M -0.00024M 0.00109M
Total cashflows from investing activities 0.00000M 0.00000M 0.00300M 0.00300M
Net borrowings 0.02M 0.02M 0.02M -0.02300M
Total cash from financing activities 0.02M 0.02M 0.02M -0.02300M
Change to operating activities 0.00662M 0.00425M 0.00160M 0.04M
Net income -0.03070M -0.02384M -0.03969M -0.02836M
Change in cash 0.00006M -0.00173M -0.00181M -0.00243M
Begin period cash flow - - - -
End period cash flow - - - -
Total cash from operating activities -0.01890M -0.01921M -0.02223M 0.02M
Issuance of capital stock - - - -
Depreciation 0.00060M 0.00105M 0.00143M 0.00646M
Other cashflows from investing activities 0.00000M 0.00000M 0.00387M 0.00000M
Dividends paid 0.00000M 0.00000M 0.00000M 0.00000M
Change to inventory 0.00000M 0.00000M 0.00000M 0.00000M
Change to account receivables -0.00001M 0.00029M 0.00012M 0.00138M
Sale purchase of stock 0.00000M 0.00000M 0.00000M 0.00000M
Other cashflows from financing activities 0.00000M 0.00000M 0.00000M 0.00000M
Change to netincome 0.00000M 0.00000M 0.01M 0.01M
Capital expenditures 0.00000M 0.00000M 0.00000M 0.00000M
Change receivables - - - -
Cash flows other operating - - - -
Exchange rate changes - - - -
Cash and cash equivalents changes - - - -
Change in working capital - - - -
Stock based compensation - - - -
Other non cash items - - - -
Free cash flow - - - -

Peer Comparison

Sector: Healthcare Industry: Biotechnology

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
CBDG
THC Farmaceuticals Inc		 0.0085 51.52% 0.03 - - 396.80 7.39 441.55 -117.7712
NVO
Novo Nordisk A/S		 -2.29 1.74% 129.31 41.58 31.15 2.13 32.99 2.11 4.70
NONOF
Novo Nordisk A/S		 3.80 2.90% 135.00 41.06 31.25 2.08 33.11 2.11 4.70
VRTX
Vertex Pharmaceuticals Inc		 3.67 0.75% 494.48 29.67 24.33 10.38 5.83 9.33 20.00
REGN
Regeneron Pharmaceuticals Inc		 22.92 2.16% 1083.78 29.07 20.12 7.57 3.82 6.95 19.42

Reports Covered

Stock Research & News

View All

Profile

THC Farmaceuticals, Inc. owns and operates non-financial institution cash-dispensing automated teller machines at third-party owned retail and commercial locations. The company's machines are placed in hotels, stores, bowling alleys, and other high customer traffic areas for small and medium sized businesses. As of June 30, 2015, it had a total of eight machines for public use along the Wasatch Front in the State of Utah. The company was formerly known as City Media, Inc. and changed its name to THC Farmaceuticals, Inc. in February 2015. THC Farmaceuticals, Inc. was founded in 2008 and is based in Scottsdale, Arizona. THC Farmaceuticals, Inc. operates as a subsidiary of Weed Growth Fund, Inc.

THC Farmaceuticals Inc

7170 East McDonald Drive, Scottsdale, AZ, United States, 85253

Key Executives

Name Title Year Born
Mr. Ed Rosenthal Pres NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.